KURA - SEC Form 4 insider transactions

SEC Form 4 filed by Director Parks Diane L.

SEC Form 4 filed by Director Collins Helen Louise

SEC Form 4 filed by Director Hasnain Faheem

SEC Form 4 filed by Director Vasconcelles Michael

SEC Form 4 filed by Director Szela Mary T

SEC Form 4 filed by Director Malley Thomas

SEC Form 4 filed by Director Schafer Carol

Chief Commercial Officer Powl Brian T. sold $110,000 worth of shares (10,000 units at $11.00) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 173,614 units (SEC Form 4)

Chief Legal Officer Bair Teresa Brophy sold $21,160 worth of shares (2,256 units at $9.38) as part of a pre-agreed trading plan, decreasing direct ownership by 0.98% to 226,931 units (SEC Form 4)

Chief Commercial Officer Powl Brian T. sold $3,122 worth of shares (339 units at $9.21) as part of a pre-agreed trading plan, decreasing direct ownership by 0.18% to 183,614 units (SEC Form 4)

Chief Operating Officer Ford Kathleen sold $20,483 worth of shares (2,257 units at $9.08) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 153,560 units (SEC Form 4)

SEC Form 4 filed by Wilson Troy Edward

SEC Form 4 filed by Malley Thomas

Chief Legal Officer Bair Teresa Brophy sold $94,828 worth of shares (11,208 units at $8.46), decreasing direct ownership by 5% to 226,931 units (SEC Form 4)

Chief Commercial Officer Powl Brian T. sold $54,266 worth of shares (6,414 units at $8.46), decreasing direct ownership by 3% to 183,275 units (SEC Form 4)

Chief Scientific Officer Burrows Francis sold $11,092 worth of shares (1,311 units at $8.46), decreasing direct ownership by 4% to 32,424 units (SEC Form 4)

Chief Operating Officer Ford Kathleen sold $15,339 worth of shares (1,813 units at $8.46), decreasing direct ownership by 1% to 153,560 units (SEC Form 4)

SVP, Finance & Accounting Doyle Thomas James sold $60,426 worth of shares (7,142 units at $8.46), decreasing direct ownership by 5% to 145,167 units (SEC Form 4)

Chief Medical Officer Leoni Mollie sold $69,209 worth of shares (8,180 units at $8.46), decreasing direct ownership by 3% to 267,274 units (SEC Form 4)

SEC Form 4 filed by President and CEO Wilson Troy Edward

SVP, Finance & Accounting Doyle Thomas James was granted 21,250 shares, increasing direct ownership by 16% to 152,309 units (SEC Form 4)

Chief Medical Officer Leoni Mollie was granted 50,000 shares, increasing direct ownership by 22% to 275,454 units (SEC Form 4)

Chief Commercial Officer Powl Brian T. was granted 50,000 shares, increasing direct ownership by 36% to 189,689 units (SEC Form 4)

Chief Operating Officer Ford Kathleen was granted 50,000 shares, increasing direct ownership by 47% to 155,373 units (SEC Form 4)

Chief Legal Officer Bair Teresa Brophy was granted 50,000 shares, increasing direct ownership by 27% to 238,139 units (SEC Form 4)

SEC Form 4 filed by Chief Scientific Officer Burrows Francis

Chief Scientific Officer Burrows Francis exercised 35,000 shares at a strike of $4.80 and sold $231,931 worth of shares (23,726 units at $9.78), increasing direct ownership by 50% to 33,735 units (SEC Form 4)

Director Hasnain Faheem exercised 10,000 shares at a strike of $3.12 and sold $109,764 worth of shares (10,000 units at $10.98) (SEC Form 4)

President and CEO Wilson Troy Edward was granted 182,500 shares, increasing direct ownership by 74% to 429,353 units (SEC Form 4)

Chief Medical Officer Leoni Mollie was granted 82,500 shares and sold $173,074 worth of shares (15,485 units at $11.18), increasing direct ownership by 42% to 225,454 units (SEC Form 4)

Chief Commercial Officer Powl Brian T. was granted 48,900 shares and sold $99,329 worth of shares (8,887 units at $11.18), increasing direct ownership by 40% to 139,689 units (SEC Form 4)

SVP, Finance & Accounting Doyle Thomas James was granted 24,967 shares and sold $50,732 worth of shares (4,539 units at $11.18), increasing direct ownership by 19% to 130,257 units (SEC Form 4)

Chief Legal Officer Bair Teresa Brophy was granted 48,900 shares and sold $98,401 worth of shares (8,804 units at $11.18), increasing direct ownership by 27% to 188,139 units (SEC Form 4)

Chief Operating Officer Ford Kathleen was granted 48,900 shares and sold $77,143 worth of shares (6,902 units at $11.18), increasing direct ownership by 66% to 105,373 units (SEC Form 4)

Chief Operating Officer Ford Kathleen gave a grant of 48,900 shares and sold $61,630 worth of shares (6,892 units at $8.94), decreasing direct ownership by 47% to 63,375 units (SEC Form 4)

President and CEO Wilson Troy Edward was granted 182,500 shares and sold $327,419 worth of shares (36,615 units at $8.94), increasing direct ownership by 144% to 246,853 units (SEC Form 4)

Chief Medical Officer Leoni Mollie was granted 82,500 shares and sold $110,114 worth of shares (12,314 units at $8.94), increasing direct ownership by 80% to 158,439 units (SEC Form 4)

Chief Legal Officer Bair Teresa Brophy was granted 48,900 shares and sold $78,736 worth of shares (8,805 units at $8.94), increasing direct ownership by 37% to 148,043 units (SEC Form 4)

Chief Commercial Officer Powl Brian T. was granted 48,900 shares and sold $79,505 worth of shares (8,891 units at $8.94), increasing direct ownership by 67% to 99,676 units (SEC Form 4)

SVP, Finance & Accounting Doyle Thomas James was granted 24,966 shares and sold $40,607 worth of shares (4,541 units at $8.94), increasing direct ownership by 23% to 109,829 units (SEC Form 4)

SEC Form 4 filed by Kura Oncology Inc.

SEC Form 4 filed by Director Vasconcelles Michael

SEC Form 4 filed by Director Parks Diane L.

SEC Form 4 filed by Director Collins Helen Louise

SEC Form 4 filed by Director Szela Mary T

SEC Form 4 filed by Director Schafer Carol

SEC Form 4 filed by Director Hasnain Faheem

SEC Form 4 filed by Director Malley Thomas

Chief Operating Officer Ford Kathleen sold $9,777 worth of shares (1,558 units at $6.28), decreasing direct ownership by 7% to 21,367 units (SEC Form 4)

Chief Legal Officer Bair Teresa Brophy sold $9,292 worth of shares (1,559 units at $5.96), decreasing direct ownership by 1% to 107,948 units (SEC Form 4)

Director Hasnain Faheem exercised 22,682 shares at a strike of $6.32 and sold $181,456 worth of shares (22,682 units at $8.00) (SEC Form 4)

SVP, Finance & Accounting Doyle Thomas James sold $38,958 worth of shares (4,949 units at $7.87), decreasing direct ownership by 5% to 88,193 units (SEC Form 4)

Chief Medical Officer Leoni Mollie sold $39,068 worth of shares (4,963 units at $7.87), decreasing direct ownership by 5% to 88,253 units (SEC Form 4)

Chief Legal Officer Bair Teresa Brophy sold $57,315 worth of shares (7,281 units at $7.87), decreasing direct ownership by 6% to 107,948 units (SEC Form 4)

Chief Operating Officer Ford Kathleen sold $14,303 worth of shares (1,817 units at $7.87), decreasing direct ownership by 8% to 21,367 units (SEC Form 4)

Chief Scientific Officer Burrows Francis sold $17,051 worth of shares (2,166 units at $7.87), decreasing direct ownership by 9% to 20,705 units (SEC Form 4)

Chief Commercial Officer Powl Brian T. sold $12,461 worth of shares (1,583 units at $7.87), decreasing direct ownership by 3% to 59,667 units (SEC Form 4)

Chief Medical Officer Leoni Mollie was granted 46,250 shares, increasing direct ownership by 98% to 93,216 units (SEC Form 4)

SEC Form 4 filed by Chief Scientific Officer Burrows Francis

SVP, Finance & Accounting Doyle Thomas James was granted 42,500 shares, increasing direct ownership by 84% to 93,142 units (SEC Form 4)